Filing Flows › Fresenius Medical Care AG (FMS) › Q3 2026
Fresenius Medical Care AG (FMS) Q3 2026 earnings results (third quarter 2026)
6-K filed Nov 3, 2026
Fresenius Medical Care AG (FMS) reported revenue of $9.9B for the third quarter 2026 (Q3 2026), +1% from a year earlier. Operating margin was 3.9%, net earnings $160M (1.6% of revenue).
Fresenius Medical Care AG, Q3 2026: revenue $9.9B (+1% year over year), operating margin 3.9%, net earnings $160M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $9.9B | — | +1% |
| Operating profit | $384M | — | -19% |
| Net earnings | $160M | — | -42% |
What changed
Revenue was €9.9B in Q3 2026, up 1% year over year. 2 a), 14 was the largest line at 50% of revenue. Healthcare services added €0.09B year over year (up 3%), 90% of the total change. Insurance contracts declined 11%.
Operating profit was €0.38B, a 3.9% margin (down 1.0 points year over year). Operating profit fell €0.09B even though revenue rose €0.10B versus a year earlier, so costs grew faster than sales. Total costs grew 2% against revenue growth of 1%. Net earnings were €0.16B, down 42% year over year. The effective tax rate was 25.7%.
Questions
What was Fresenius Medical Care AG's revenue in the third quarter 2026?
Fresenius Medical Care AG (FMS) reported revenue of $9.9B for the third quarter 2026 (Q3 2026), +1% from a year earlier.
Was Fresenius Medical Care AG profitable in the third quarter 2026?
Operating profit was $384M (3.9% of revenue) and net earnings $160M.